Details for New Drug Application (NDA): 202047
✉ Email this page to a colleague
The generic ingredient in RIZATRIPTAN BENZOATE is rizatriptan benzoate. There are twenty-two drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the rizatriptan benzoate profile page.
Summary for 202047
Tradename: | RIZATRIPTAN BENZOATE |
Applicant: | Creekwood Pharms |
Ingredient: | rizatriptan benzoate |
Patents: | 0 |
Pharmacology for NDA: 202047
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Suppliers and Packaging for NDA: 202047
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET;ORAL | 202047 | ANDA | Creekwood Pharmaceuticals LLC | 82619-111 | 82619-111-01 | 30 TABLET in 1 BOTTLE (82619-111-01) |
RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET;ORAL | 202047 | ANDA | Creekwood Pharmaceuticals LLC | 82619-111 | 82619-111-02 | 1000 TABLET in 1 BOTTLE (82619-111-02) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE | ||||
Approval Date: | Dec 31, 2012 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE | ||||
Approval Date: | Dec 31, 2012 | TE: | AB | RLD: | No |
Complete Access Available with Subscription